NextGeneration DNA
Firebird Biomolecular Sciences delivers reagent innovations to the research, synthetic biology, and clinical diagnostics communities. The company develops next-generation nucleic acid technologies including AEGIS (Artificially Expanded Genetic Information Systems), SAMRS (Self-Avoiding Molecular Recognition Systems), reversible terminators, and biversal nucleotides. Products address challenges in PCR multiplexing, DNA sequencing, and oligo synthesis for laboratory and clinical applications.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountNov 2007
Create a free account to see which investors have funded this company.
Create Free AccountAI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Provides comprehensive molecular profiling and AI-driven precision oncology services for physicia...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Clinical-stage biopharma developing precision medicines for cancer and other serious diseases usi...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
